Meeting of the National Biodefense Science Board, 32029 [08-1321]

Download as PDF Federal Register / Vol. 73, No. 109 / Thursday, June 5, 2008 / Notices person. The hours burden imposed by the pretest will be approximately 8.5 hours (100 respondents 5 minutes for each). The FTC staff estimates that the survey of 1,000 respondents also will require no more than 5 minutes per person or 83.5 hours (1,000 respondents 5 minutes for each). Thus, the estimated total hours burden attributable to the telephone survey research is 242 hours (150 + 8.5 + 83.5). The combined total hours burden attributable to both research projects is 378.5 hours (242 + 136.5). 3. Estimated Cost Burden The cost per respondent should be negligible. Participation is voluntary and will not require any labor expenditures by respondents nor capital, start-up, operation, maintenance, or other similar costs. William Blumenthal General Counsel [FR Doc. E8–12590 Filed 6–4–08: 8:45 am] [Billing code: 6750–01–S] DEPARTMENT OF HEALTH AND HUMAN SERVICES Meeting of the National Biodefense Science Board Department of Health and Human Services, Office of the Secretary. ACTION: Notice. yshivers on PROD1PC62 with NOTICES AGENCY: SUMMARY: As stipulated by the Federal Advisory Committee Act, the Department of Health and Human Services is hereby giving notice that the National Biodefense Science Board (NBSB) will be holding a meeting. The meeting is open to the public. DATES: The meeting will be held on June 18, 2008, from 8:30 a.m. to 5 p.m. ADDRESSES: The Sheraton National Hotel, 900 S. Orme Street, Arlington, VA 22204. Phone: 703–521–1900. FOR FURTHER INFORMATION, CONTACT: CAPT Leigh A. Sawyer, D.V.M., M.P.H., Executive Director, National Biodefense Science Board, Office of the Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services, 200 Independence Ave SW., Room 638G, Washington, DC 20201; 202–205–3815; fax: 202–205– 0613; e-mail address: leigh.sawyer@hhs.gov. Pursuant to section 319M of the Public Health Service Act (42 U.S.C. 247d–7f) and section 222 of the Public Health Service SUPPLEMENTARY INFORMATION: VerDate Aug<31>2005 14:51 Jun 04, 2008 Jkt 214001 Act (42 U.S.C. 217a), the Department of Health and Human Services established the National Biodefense Science Board. The Board shall provide expert advice and guidance to the Secretary on scientific, technical, and other matters of special interest to the Department of Health and Human Services regarding current and future chemical, biological, nuclear, and radiological agents, whether naturally occurring, accidental, or deliberate. The Board may also provide advice and guidance to the Secretary on other matters related to public health emergency preparedness and response. Topics to be discussed include updates from the Pandemic Influenza Working Group, the Disaster Medicine Working Group, the Markets and Sustainability Working Group, and the U.S. Medical Countermeasure Research and Development Processes for Chemical, Biological, Radiological and Nuclear Agents Working Group. Additionally, the NBSB will discuss preparedness and planning issues related to at-risk populations and pandemic influenza , consider issues related to medical response and preparedness for radiological and nuclear events, and receive an update on the activities of the Homeland Security Presidential Directive #21, Federal Biosurveillance Working Group. The NBSB will also receive a briefing on issues related to the Department of Health and Human Services development of MedKits. This agenda is subject to change as priorities dictate. A tentative schedule will be made available on June 6, 2008 at the NBSB Web site, https://www.hhs.gov/aspr/ omsph/nbsb. Any member of the public interested in presenting oral comments at the meeting may notify the Contact person listed on this notice by June 11, 2008. Interested individuals and representatives of an organization may submit a letter of intent and a brief description of the organization represented. In addition, any interested person may file written comments with the committee. All written comments must be received prior to June 11, 2008 and should be sent by e-mail with ‘‘NBSB Public Comment’’ as the subject line or by regular mail to the Contact person listed above. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the designated contact person. PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 32029 Dated: May 30, 2008. RADM William C. Vanderwagen, Assistant Secretary for Preparedness and Response, U.S. Department of Health and Human Services. [FR Doc. 08–1321 Filed 6–2–08; 2:27pm] BILLING CODE 4150–37–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA–2005–N–0474] (formerly Docket No. 2005N–0210) Agency Information Collection Activities; Proposed Collection; Comment Request; Veterinary Feed Directive AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration (FDA) is announcing an opportunity for public comment on the proposed collection of certain information by the agency. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on reporting and recordkeeping requirements for distribution and use of Veterinary Feed Directive drugs and animal feeds containing Veterinary Feed Directive drugs. DATES: Submit written or electronic comments on the collection of information by August 4, 2008. ADDRESSES: Submit electronic comments on the collection of information to https:// www.regulations.gov. Submit written comments on the collection of information to the Division of Dockets Management (HFA–305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. All comments should be identified with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Denver Presley, Jr., Office of the Chief Information Officer (HFA–250), Food and Drug Administration, 5600 Fishers Lane, Rockville, MD 20857, 301–827– 1472. Under the PRA (44 U.S.C. 3501–3520), Federal agencies must obtain approval from the SUPPLEMENTARY INFORMATION: E:\FR\FM\05JNN1.SGM 05JNN1

Agencies

[Federal Register Volume 73, Number 109 (Thursday, June 5, 2008)]
[Notices]
[Page 32029]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 08-1321]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES


Meeting of the National Biodefense Science Board

AGENCY: Department of Health and Human Services, Office of the 
Secretary.

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: As stipulated by the Federal Advisory Committee Act, the 
Department of Health and Human Services is hereby giving notice that 
the National Biodefense Science Board (NBSB) will be holding a meeting. 
The meeting is open to the public.

DATES: The meeting will be held on June 18, 2008, from 8:30 a.m. to 5 
p.m.

ADDRESSES: The Sheraton National Hotel, 900 S. Orme Street, Arlington, 
VA 22204. Phone: 703-521-1900.

FOR FURTHER INFORMATION, CONTACT: CAPT Leigh A. Sawyer, D.V.M., M.P.H., 
Executive Director, National Biodefense Science Board, Office of the 
Assistant Secretary for Preparedness and Response, U.S. Department of 
Health and Human Services, 200 Independence Ave SW., Room 638G, 
Washington, DC 20201; 202-205-3815; fax: 202-205-0613; e-mail address: 
leigh.sawyer@hhs.gov.

SUPPLEMENTARY INFORMATION: Pursuant to section 319M of the Public 
Health Service Act (42 U.S.C. 247d-7f) and section 222 of the Public 
Health Service Act (42 U.S.C. 217a), the Department of Health and Human 
Services established the National Biodefense Science Board.
    The Board shall provide expert advice and guidance to the Secretary 
on scientific, technical, and other matters of special interest to the 
Department of Health and Human Services regarding current and future 
chemical, biological, nuclear, and radiological agents, whether 
naturally occurring, accidental, or deliberate. The Board may also 
provide advice and guidance to the Secretary on other matters related 
to public health emergency preparedness and response.
    Topics to be discussed include updates from the Pandemic Influenza 
Working Group, the Disaster Medicine Working Group, the Markets and 
Sustainability Working Group, and the U.S. Medical Countermeasure 
Research and Development Processes for Chemical, Biological, 
Radiological and Nuclear Agents Working Group. Additionally, the NBSB 
will discuss preparedness and planning issues related to at-risk 
populations and pandemic influenza , consider issues related to medical 
response and preparedness for radiological and nuclear events, and 
receive an update on the activities of the Homeland Security 
Presidential Directive 21, Federal Biosurveillance Working 
Group. The NBSB will also receive a briefing on issues related to the 
Department of Health and Human Services development of MedKits. This 
agenda is subject to change as priorities dictate. A tentative schedule 
will be made available on June 6, 2008 at the NBSB Web site, https://
www.hhs.gov/aspr/omsph/nbsb.
    Any member of the public interested in presenting oral comments at 
the meeting may notify the Contact person listed on this notice by June 
11, 2008. Interested individuals and representatives of an organization 
may submit a letter of intent and a brief description of the 
organization represented. In addition, any interested person may file 
written comments with the committee. All written comments must be 
received prior to June 11, 2008 and should be sent by e-mail with 
``NBSB Public Comment'' as the subject line or by regular mail to the 
Contact person listed above. Individuals who plan to attend and need 
special assistance, such as sign language interpretation or other 
reasonable accommodations, should notify the designated contact person.

    Dated: May 30, 2008.
RADM William C. Vanderwagen,
Assistant Secretary for Preparedness and Response, U.S. Department of 
Health and Human Services.
[FR Doc. 08-1321 Filed 6-2-08; 2:27pm]
BILLING CODE 4150-37-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.